BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 16, 2000
View Archived Issues
Licensing opportunity from NIH: vaccinia virus vector for cancer therapy
Read More
Licensing opportunity from NIH: subunit vaccine for viral diseases
Read More
CytRx and Merck enter TranzFect agreement
Read More
Verteporfin shows promise in clinical trials for the treatment of skin cancer
Read More
MediGene to acquire NeuroVir
Read More
NeoTherapeutics to focus on higher doses of Neotrofin
Read More
Promising phase III results with Gliadel as first-line treatment of malignant glioma
Read More
Completion of Elan's acquisition of Dura announced
Read More
Genelabs Technologies and Watson enter collaboration and licensing agreement for lupus drug
Read More
Icos receives license from Stanford for novel antibiotic target
Read More
PDT with MV-6401 prevents neointimal formation following carotid artery angioplasty in rats
Read More
Selective ETA antagonism with TBC-3711 as a new approach to neonatal pulmonary hypertension
Read More
Hemodynamic effects and safety of conivaptan in advanced heart failure discussed at AHA meeting
Read More
AHA news: new MTP inhibitor markedly reduces postprandial fat absorption in humans
Read More
Phase I/II data indicate efficacy and safety of TP-10 in preventing post-CPB inflammation in infants
Read More
Acronycine analogue S-23906 confirmed as a potential development candidate for solid tumors
Read More
Trizivir anti-HIV therapy approved by FDA
Read More
Potential cellular mechanism for adverse cardiac effects of Herceptin described at AHA sessions
Read More
ALS treatment now available from Aventis in Canada
Read More
Chemokine receptor-modulating pyrrolidine derivatives described by Merck
Read More
Novel tetrahydropyridazines from Merck KGaA inhibit PDE4 and TNF
Read More
BASF presents small molecules with tyrosine kinase-inhibitory activity
Read More
European Commission grants orphan drug status to Mylotarg for treatment of AML
Read More
NOS inhibitors derived from lipoic acid described in recent patent by SCRAS
Read More
Series of selective Tgamma9delta2 lymphocyte inhibitors emerges from joint U.S.-French R&D
Read More
Promising first clinical data on NESP in anemic cancer patients presented at ESMO
Read More
SB's new ET receptor antagonists covered by U.S. patent
Read More
Naeja describes preparation, activity and use of new cathepsin inhibitors
Read More